Exchange Traded Concepts, LLC Vor Biopharma Inc. Transaction History

Exchange Traded Concepts, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	SELL	$0.72 - $1.74 $12,767 - $30,853	-17,732 Reduced 10.69%	148,073 $106,000
Q3 2024 Oct 10, 2024	BUY	$0.7 - $1.1 $33,611 - $52,818	48,017 Added 40.77%	165,805 $116,000
Q2 2024 Aug 13, 2024	SELL	$1.0 - $2.2 $36,648 - $80,625	-36,648 Reduced 23.73%	117,788 $117,000
Q1 2024 Apr 15, 2024	BUY	$1.8 - $2.85 $169,678 - $268,658	94,266 Added 156.67%	154,436 $366,000
Q4 2023 Jan 05, 2024	BUY	$1.66 - $2.63 $25,328 - $40,128	15,258 Added 33.97%	60,170 $135,000

Q3 2023 Oct 18, 2023	BUY	$2.1 - $3.35 $36,466 - $58,172	17,365 Added 63.04%	44,912 $95,000
Q2 2023 Jul 20, 2023	BUY	$3.09 - $5.33 $85,120 - $146,825	27,547 New	27,547 $85,000

872K

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $383M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.